Lexaria Bioscience
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LEXX and other ETFs, options, and stocks.About LEXX
Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. It operates through the IP licensing segment which generates revenue from customers by licensing its proprietary DehydraTECH technology.
CEORichard C. Christopher
CEORichard C. Christopher
Employees7
Employees7
HeadquartersKelowna, British Columbia
HeadquartersKelowna, British Columbia
Founded2004
Founded2004
Employees7
Employees7
LEXX Key Statistics
Market cap31.58M
Market cap31.58M
Price-Earnings ratio-2.02
Price-Earnings ratio-2.02
Dividend yield—
Dividend yield—
Average volume193.23K
Average volume193.23K
High today$1.44
High today$1.44
Low today$1.25
Low today$1.25
Open price$1.29
Open price$1.29
Volume571.25K
Volume571.25K
52 Week high$2.43
52 Week high$2.43
52 Week low$0.7749
52 Week low$0.7749
Stock Snapshot
Lexaria Bioscience(LEXX) stock is priced at $1.34, giving the company a market capitalization of 31.58M. It carries a P/E multiple of -2.02.
On 2025-12-12, Lexaria Bioscience(LEXX) stock traded between a low of $1.25 and a high of $1.44. Shares are currently priced at $1.34, which is +7.3% above the low and -6.9% below the high.
The Lexaria Bioscience(LEXX)'s current trading volume is 571.25K, compared to an average daily volume of 193.23K.
In the last year, Lexaria Bioscience(LEXX) shares hit a 52-week high of $2.43 and a 52-week low of $0.77.
In the last year, Lexaria Bioscience(LEXX) shares hit a 52-week high of $2.43 and a 52-week low of $0.77.
People also own
Based on the portfolios of people who own LEXX. This list is generated using Robinhood data, and it’s not a recommendation.